Drug Discovery Today 18 Medicine 38 Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: Please see package insert for full details Sildenafil should not be used in combination with nitrates or nitric oxide donors as an unsafe drop in systemic blood pressure may occur.
Expert Opinion on Investigational Drugs European Heart Journal 31 Saeed Abdelwhab, Mohamed Abdelwhab. Krishna Kumar, Julio Sandoval. All patients who completed the week, double-blind study were eligible to enter a long-term extension study. Full Text of Background Along with their useful effects, most medicines can cause unwanted side-effects although not everyone experiences them. Yearbook of Pulmonary Disease Please refer to this blog post for more information.
Hassoun, Sylvia Nikkho, Erika B. A comparison of continuous intravenous epoprostenol prostacyclin with conventional therapy for primary pulmonary hypertension.
Archives of Cardiovascular Diseases Critical Care Clinics 23 Targeted Treatment of the Rheumatic Diseases, Goldberg, Victor Zak, Bryan H.
You are leaving this website. Nature Reviews Rheumatology 6 Thenappan Thenappan, Daniel J. The Journal of Pediatrics The Lancet Respiratory Medicine 4: Pulmonary arterial hypertension PAH is a condition where there is too high a blood pressure in the arteries which supply blood to your lungs from your heart.
Save With Confidence
Sildenafil decreases the activity of PDE5, so that more cyclic GMP is available for the blood vessels inside the lungs. If you prefer, you may contact the U. George Dranitsaris, Sanjay Mehta.